Small Molecules
13 August 2013
ViiV Healthcare announces U.S. approval of Tivicay® (dolutegravir) for the treatment of HIV-18 August 2013
Sucampo Announces Positive Top-Line Results in Phase 1a Trials of Cobiprostone and SPI-3608 (2)8 August 2013
European Commission Approves VELCADE® as a Frontline Induction Therapy before Stem Cell Transplantation8 August 2013
Threshold Pharmaceuticals Initiates Phase 2 Study of TH-302 in Patients With Advanced Melanoma7 August 2013
Orexo: First patient dosed in new study on long-term adherence to treatment of opioid dependence with Zubsolv7 August 2013
Novartis study of Afinitor® in advanced liver cancer does not meet primary endpoint of overall survival6 August 2013
Trophos completes patient enrolment in a first study of olesoxime in relapsing remitting Multiple Sclerosis5 August 2013
Reduction in Lung Fibrosis With the Anti-Galectin Drug GR-MD-02 Revealed in Preclinical DataNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports